
Trontinemab: A New Hope for Alzheimer’s
Trontinemab, an experimental drug developed by Roche, has sparked excitement in large trials for slowing Alzheimer’s faster and safer than anything before.

Trontinemab, an experimental drug developed by Roche, has sparked excitement in large trials for slowing Alzheimer’s faster and safer than anything before.

Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.

Does pain relief risk cognitive cost? A major new study of almost 200,000 people says yes—and the price may be higher than we thought.

Why Do Babies Have More Alzheimer’s Protein Than Adults? A Surprising Clue to Future Treatments

Diagnosing the right dementia type often takes months. It can make a big difference. Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan — a transformative advance in early, accurate diagnosis.

Bill Gates says, “I am blown away by how much we have learned about Alzheimer’s disease over the last couple years.” See his compelling video and insight-filled blog post.

Adopting the MIND diet—even later in life—is linked with reduced dementia risk

See one of the largest and most comprehensive studies identifying where dementia occurs most often.

Sleep aid lemborexant (better known by its brand name Dayvigo) showed 40% more hippocampal brain volume than other drugs.

Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.

New research reveals that Leqembi’s Fc region switches on microglia — the brain’s immune cells — helping them clear toxic amyloid. Here’s why that mechanism matters for treatment and safety.

People with dementia are enjoying yoga and dance classes at the Alzheimer’s Association. See why caregivers find the classes “EXTREMELY helpful.”

Swiss researchers find that people with certain personality traits are protected against Alzheimer’s disease, including those who are less agreeable, had natural curiosity, and were nonconformists. Find out why.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.

When a hurricane hits Florida — or anywhere that has a very large population of people with dementia, there are special preparations that should be made by those living with dementia. Check these dementia-in-a-storm readiness lists.

In gardening, people with Alzheimer’s grow fresh plants along with better thinking. It’s a pleasant way to make things easier.
No spam, only news and updates.


